SCHEMBL5365218

SCHEMBL5365218

Nc1ccc(S(=O)(=O)Cl)c2ccccc12.O=S(=O)(Cl)c1ccc2ccc3cccc4ccc1c2c34

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 3/20 0.43
CYP1A2 P05177 2/20 0.43
THRB P10828 1/20 0.43
TTR P02766 1/20 0.41
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40
HPRT1 P00492 1/20 0.40
AURKA O14965 1/20 0.40
AURKB Q96GD4 1/20 0.40
NR4A1 P22736 1/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 2/20 0.38
KEAP1 Q14145 1/20 0.38
NSD2 O96028 6/20 0.37
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17294739 0.88 TTR (0.44) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL1285825 0.86 ALDH1A1 (0.46) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL30672506 0.86 ALDH1A1 (0.46) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL7729945 0.84 CA1 (0.53) ALDH1A1HPGDHSD17B10CYP1A2TTR
SCHEMBL38143 0.84 TTR (0.50) ALDH1A1HPGDHSD17B10TTRAURKA
SCHEMBL28444885 0.82 TTR (0.48) ALDH1A1HPGDHSD17B10TTRAURKA
SCHEMBL28977925 0.81 TTR (0.52) ALDH1A1HPGDHSD17B10TTRCYP3A4
SCHEMBL28977921 0.79 TTR (0.46) ALDH1A1HPGDHSD17B10TTRAURKA
SCHEMBL5365212 0.79 CA2 (0.52) HSD17B10CYP1A2TSHRNSD2CA2
SCHEMBL28977927 0.78 TTR (0.46) ALDH1A1HPGDHSD17B10TTRAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867633-A1 Polyamine analogues as therapeutic and diagnostic agents MediQuest Therapeutics, Inc. (US) 2007-12-19 EP disclosed
US-7208528-B1 Polyamine analogues as therapeutic and diagnostic agents MEDIQUEST THERAPEUTICS, INC. (US) 2007-04-24 US disclosed
US-7160923-B1 Polyamine analogues as therapeutic and diagnostic agents MEDIQUEST THERAPEUTICS, INC. (US) 2007-01-09 US disclosed
EP-1085011-A1 Novel polyamine analogues as therapeutic and diagnostic agents ORIDIGM CORPORATION (US) 2001-03-21 EP disclosed
US-6172261-B1 BIOSYNTHESIS USING CHAIN EXTENSION ORIDIGM CORPORATION 2001-01-09 US disclosed
EP-1001927-A2 NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS ORIDIGM CORPORATION (US) 2000-05-24 EP disclosed
WO-1999003823-A2 NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS ORIDIGM CORPORATION (US) 1999-01-28 WO disclosed